HighTower Advisors
VSTM icon

HighTower Advisors’s Verastem VSTM Stock Holding History

HighTower Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-960
Closed -$23K – 3711
2021
Q4 		$23K Sell
960
-208
-18% -$6.56K ﹤0.01% 3098
2021
Q3 		$43K Hold
1,168
– – ﹤0.01% 2949
2021
Q2 		$57K Sell
1,168
-792
-40% -$33K ﹤0.01% 2878
2021
Q1 		$57K Buy
+1,960
New +$54.9K ﹤0.01% 2817
2020
Q4 		– Sell
-1,188
Closed -$16K – 2878
2020
Q3 		$16K Hold
1,188
– – ﹤0.01% 2386
2020
Q2 		$24K Buy
+1,188
New +$31.4K ﹤0.01% 2245
2017
Q4 		– Sell
-1,140
Closed -$64K – 2391
2017
Q3 		$64K Buy
1,140
+305
+37% +$14.4K ﹤0.01% 2067
2017
Q2 		$21K Buy
+835
New +$21.2K ﹤0.01% 2074

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

HighTower Advisors's VSTM Position: Q1 2022 in Review

HighTower Advisors sold out of Verastem (VSTM) in Q1 2022, closing a stake of 960 shares — an estimated $23K sold.

HighTower Advisors first reported a position in VSTM in Q2 2017 and held it in 8 quarters. The position peaked at $64K in Q3 2017. 141 funds tracked by Wall St. Rank hold VSTM as of Q1 2022.

  • HighTower Advisors reported no remaining Verastem position as of Q1 2022 after selling out during the quarter.
  • HighTower Advisors sold 960 Verastem shares in Q1 2022, an estimated $23K.
  • HighTower Advisors first reported a position in Verastem in Q2 2017 and held it in 8 quarters.
  • HighTower Advisors's Verastem position peaked at $64K in Q3 2017.
  • 141 funds tracked by Wall St. Rank held Verastem as of Q1 2022.

Based on HighTower Advisors's 13F filing for Q1 2022, filed 12 May 2022.